0001610717-23-000141.txt : 20230612
0001610717-23-000141.hdr.sgml : 20230612
20230612164547
ACCESSION NUMBER: 0001610717-23-000141
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230608
FILED AS OF DATE: 20230612
DATE AS OF CHANGE: 20230612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waddill William D.
CENTRAL INDEX KEY: 0001553338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39402
FILM NUMBER: 231008753
MAIL ADDRESS:
STREET 1: C/O CALITHERA BIOSCIENCES
STREET 2: 343 OYSTER POINT BLVD, SUITE 200
CITY: SO. SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Annexon, Inc.
CENTRAL INDEX KEY: 0001528115
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 275414423
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1400 SIERRA POINT PARKWAY
STREET 2: BLDG C, SUITE 200
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: (650)-822-5500
MAIL ADDRESS:
STREET 1: 1400 SIERRA POINT PARKWAY
STREET 2: BLDG C, SUITE 200
CITY: BRISBANE
STATE: CA
ZIP: 94005
4
1
form4.xml
X0407
4
2023-06-08
0001528115
Annexon, Inc.
ANNX
0001553338
Waddill William D.
C/O ANNEXON, INC.
1400 SIERRA POINT PKWY, BLDG C, STE 200
BRISBANE
CA
94005
true
false
Stock Option (Right to Buy)
2.88
2023-06-08
4
A
0
24000
0
A
2033-06-08
Common Stock
24000
24000
D
The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 8, 2023 or (ii) the next Annual Meeting following June 8, 2023, subject to Reporting Person's continuous service as a director until such vesting date.
/s/ Jennifer Lew, as Attorney-in-Fact for William D. Waddill
2023-06-12